Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 01, 2015 3:30 PM ET


Company Overview of Cellectis S.A.

Executive Profile

Frederick W. Alt M.D., Ph.D.

AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships


Prof. Frederick W. Alt, also known as Fred, MD, Ph.D. served as Scientific Director of Immune Disease Institute, Inc. (Also called as CBR (Center for Blood Research)) since 2005. Mr. Alt oversees research and training activities at IDI, and leads principal investigators in the establishment of institutional research goals. He is a world-leading expert in the fields of Immunology and Cancer Biology. He has been the Senior investigator at IDI since 1991. He serves as an ...

Corporate Headquarters

8 rue de la Croix Jarry
Paris, Ile-de-France 75013


Phone: 33 1 81 69 16 00
Fax: --

Board Members Memberships

Director and Chairman of Scientific Advisory Board


Unknown/Other Education
Stanford University
PhD 1977
Stanford University
Bachelor's Degree
Brandeis University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Jeffrey R. Immelt Executive Chairman and Chief Executive Officer
General Electric Company
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
Edward O. Lanphier IIFounder, Chief Executive Officer, President, Director and Member of Clinical Review Committee
Sangamo Biosciences Inc.
Richard Ridinger Chief Executive Officer
Lonza Group Ltd
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cellectis S.A., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at